ATG16L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.415800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.849000E-01
Normal-vs-Stage2
2.844200E-01
Normal-vs-Stage3
7.988600E-01
Normal-vs-Stage4
2.604600E-01
Stage1-vs-Stage2
5.984800E-01
Stage1-vs-Stage3
3.152000E-01
Stage1-vs-Stage4
4.742600E-01
Stage2-vs-Stage3
1.205000E-01
Stage2-vs-Stage4
7.021800E-01
Stage3-vs-Stage4
1.699760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.557000E-01
Normal-vs-AfricanAmerican
4.903600E-01
Normal-vs-Asian
2.671200E-01
Caucasian-vs-AfricanAmerican
9.233400E-01
Caucasian-vs-Asian
4.792200E-01
AfricanAmerican-vs-Asian
6.309000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.671600E-01
Normal-vs-Female
4.672600E-01
Male-vs-Female
1.028400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.774200E-01
Normal-vs-Age(41-60Yrs)
2.357000E-01
Normal-vs-Age(61-80Yrs)
4.396800E-01
Normal-vs-Age(81-100Yrs)
2.379000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.587000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.190200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.418200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.105800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.832000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.051200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.156400E-01
Normal-vs-Daily Drinker
4.559400E-01
Normal-vs-Weekly Drinker
4.341400E-01
Normal-vs-Occasional Drinker
2.436800E-01
Normal-vs-Social Drinker
2.859400E-01
Non Drinker-vs-Daily Drinker
5.845000E-01
Non Drinker-vs-Weekly Drinker
8.477600E-01
Non Drinker-vs-Occasional Drinker
3.812800E-01
Non Drinker-vs-Social Drinker
3.635400E-01
Daily Drinker-vs-Weekly Drinker
7.718000E-01
Daily Drinker-vs-Occasional Drinker
1.596590E-01
Daily Drinker-vs-Social Drinker
7.807400E-01
Weekly Drinker-vs-Occasional Drinker
3.497600E-01
Weekly Drinker-vs-Social Drinker
6.045000E-01
Occasional Drinker-vs-Social Drinker
9.659700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.280300E-02
Normal-vs-Grade 2
4.939400E-03
Normal-vs-Grade 3
5.155400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.993500E-04
Grade 1-vs-Grade 3
3.956900E-04
Grade 1-vs-Grade 4
9.280300E-02
Grade 2-vs-Grade 3
2.818200E-01
Grade 2-vs-Grade 4
4.939400E-03
Grade 3-vs-Grade 4
5.155400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.886200E-01
Normal-vs-NonDiabetic
3.501000E-01
Diabetic-vs-NonDiabetic
4.829800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.565000E-01
Normal-vs-NoPancreatitis
4.061000E-01
Pancreatitis-vs-NoPancreatitis
4.929600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.013600E-01
Normal-vs-N1
3.268200E-01
N0-vs-N1
6.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.392400E-02
Normal-vs-TP53-NonMutant
7.323400E-01
TP53-Mutant-vs-TP53-NonMutant
8.46070000000143E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
